Authors
Loading...
Updated results from the RUBY trial demonstrate hematopoietic stem cell therapy enhances fetal hemoglobin and reduces sickle cell symptoms in patients.
Bhatia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: